AMANDA O'NEILL: Open Payments
NPI 1851803837 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 24 payments from 8 companies in 2025. Trend: 2023 $128 · 2024 $717 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $105 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 1 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $22 |
Products named: VYNDAQEL, JARDIANCE, WAINUA, CAMZYOS, Kerendia, ENTRESTO, UPTRAVI, LifeVest.
Industry payments across CT — which companies pay providers there.
